As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL)—a biomarker of neuronal damage—levels in spinal fluid were lower in ...

Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only ...

This image shows three brain cells with the faulty protein that causes Huntington’s disease. The bright yellow cell in the middle has built up a clump of this protein inside it. The blue spots in the ...

Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But last ...

“Beyond UniQure, the pipeline includes highly promising approaches that will ideally move the goal from merely managing ...

Sex influences how genetic and age-related factors translate into clinical and neuroimaging trajectories in Huntington disease.

Scientists may have discovered the first therapy for Huntington’s disease, a brain disorder that until now has had no effective treatments. Researchers at the University of College London (UCL) ...

Huntington's disease is a fatal, hereditary neurological disorder mostly striking people between the ages of 30 and 50. In 1872, a young physician, Dr. George Huntington, first described the disease ...

In a small trial, a gene therapy injected into the brain slowed the disease by 75 percent over three years. Huntington’s disease is extremely cruel. Symptoms start with random, uncontrollable twitches ...

MRI of a brain with Huntington's Disease. Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University ...